Comparative Assessment of Somatostatin Analogues in Pancreatic Surgical Interventions

V.M. Kopchak, I.V. Khomyak, K.V. Kopchak, O.V. Duvalko, S.V. Andronik, L.O. Pererva, V.P. Serdyuk, G.G. Shevkolenko, V.V. Khanenko

Abstract


The paper considers the aspects about somatostatin analogues use in the patients after pancreatic surgical intervention. There are presented the data of he investigation of Octra® effectiveness in comparison with other somatostatin analogues for preventing the complications induced by the pancreatic surgery.


Keywords


somatostatin; pancreas; surgery; complication; Octra®

References


Randomized controlled multicentre study of the prevention of complications by octreotide in patients under going surgery for chronic pancreatitis / Friess H., Beger H.G., Sulkowski U., Becker H., Hofbauer B., Dennler H.J., Büchler M.W. // Br. J. Surg. — 1995 Sep. — 82(9). — 1270-3.

Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial / Montorsi M., Zago M., Mosca F., Capussotti L., Zotti E., Ribotta G., Fegiz G., Fissi S., Roviaro G., Peracchia A. et al. // Surgery. — 1995 Jan. — 117(1). — 26-31.

Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease / A.M. Lowy, J.E. Lee, P.W. Pisters, B.S. Davidson, C.J. Fenoglio, P. Stanford, R. Jinnah, and D.B. Evans // Ann. Surg. — 1997 November. — 226(5). — 632-641.

Does Prophylactic Octreotide Decrease the Rates of Pancreatic Fistula and Other Complications аfter Pancreaticoduodenectomy? Results of a Prospective Randomized Placebo-Controlled Trial / Charles J. Yeo, John L. Cameron, Keith D. Lillemoe, Patricia K. Sauter, Jo Ann Coleman, Taylor A. Sohn, Kurtis A. Campbell, and Michael A. Choti // Ann. Surg. — 2000 September. — 232(3). — 419-429.

Somatostatin and octreotide in the prevention of postoperative pancreatic complication sand the treatmen to fenterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials / Li-Ling J., Irving M. // Br. J. Surg. — 2001 Feb. — 88(2). — 190-9.

Randomized controlled multicentre trial of somatostatin infusion after pancreaticoduodenectomy. / Gouillat C., Chipponi J., Baulieux J., Partensky C., Saric J., Gayet B. // Br. J. Surg. — 2001 Nov. — 88(11). — 1456-62.

The potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy: a prospective, multicenter, double-blinded, randomized, placebo-controlled trial / Sarr M.G.; Pancreatic Surgery Group // J. Am. Coll. Surg. — 2003 Apr. — 196(4). — 556-64.

Role of somatostatin in the prevention of pancreatic stump-related morbidity following elective pancreaticoduodenectomy in high-risk patient sand elimination of surgeon-related factors: prospective, randomized, controlled trial / Shan Y.S., Sy E.D., Lin P.W. // World J. Surg. — 2003 Jun. — 27(6). — 709-14.

Role of un labelled somatostatin analogues in the prevention of complications after elective pancreatic and peripancreatic surgery: a critical review / Falconi M., Salvia R., Mascetta G., Mantovani W., Sartori N., Butturini G., Bassi C., Pederzoli P. // Dig. Liver Dis. — 2004 Feb. — 36 Suppl 1. — S121-7.

Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection: a prospective, multicenter randomized controlled trial / Suc B., Msika S., Piccinini M., Fourtanier G., Hay J.M., Flamant Y., Fingerhut A., Fagniez P.L., Chipponi J.; French Associations for Surgical Research // Arch. Surg. — 2004 Mar. — 139(3). — 288-94.

Meta-analysis of the value of somatostatin and it sanalogues in reducing complications a sociated with pancreatic surgery / Connor S., Alexakis N., Garden O.J., Leandros E., Bramis J., Wigmore S.J. // Br. J. Surg. — 2005 Sep. — 92(9). — 1059-67.

Інструкція для медичного застосування препарату Октра.




DOI: https://doi.org/10.22141/2224-0586.2.49.2013.89723

Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 EMERGENCY MEDICINE

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru